Evaluation of the Periodontal Status After the Treatment of Palatally Impacted Canines Using Acceleration Procedures
Launched by DAMASCUS UNIVERSITY · Nov 30, 2022
Trial Information
Current as of May 24, 2025
Completed
Keywords
ClinConnect Summary
Patients with palatally impacted maxillary canines will be treated using fixed appliances assisted by some surgical procedures. The effects of this treatment approach on the periodontal status will be assessed using periodontal measurements.
There are two groups :
1. conventional treatment group
2. minimally-invasive corticotomy-assisted treatment group Patients will be allocated to the two groups randomly. Data will be collected using periodontal variables.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age of patients: 18-28 years.
- • 2. Palatal or Mid-alveolar impacted canine.
- • 3. There is no previous orthodontic treatment.
- • 4. Healthy periodontal tissues and good oral health (i.e., the Plaque Index is less or equal to 1 according to Loe and Silness(1963).
- • 5. The patient does not take any drug that may interfere with the tooth movement (Cortisone, NSAIDs ...).
- • 6. Mild or no crowding on the upper jaw.
- • 7. No history of previous trauma to the maxillofacial region or surgical interventions.
- Exclusion Criteria:
- • 1. Any systemic diseases that would affect tooth movement
- • 2. Antidepressant prevents oral surgery
- • 3. Any congenital syndromes or cleft lip and palate cases
- • 4. Bad oral health
- • 5. Previous orthodontic treatment
About Damascus University
Damascus University, a prestigious institution located in Syria, is committed to advancing medical research and healthcare innovation through its clinical trial initiatives. With a focus on fostering collaboration between academia and clinical practice, the university aims to enhance the understanding of various medical conditions and improve patient outcomes. By leveraging its extensive network of researchers, healthcare professionals, and state-of-the-art facilities, Damascus University strives to contribute to the global body of knowledge in the medical field and support the development of effective therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Damascus, , Syrian Arab Republic
Patients applied
Trial Officials
Mahran R Mousa, DDS,MSc
Study Chair
Department of orthodontics, Damascus University, Syria
Mohammad Y. Hajeer, DDS,MSc,PhD
Study Director
Department of orthodontics, Damascus University, Syria
Omar Heshmeh, DDS,MSc,PhD
Study Director
Department of oral and maxillofacial surgery, Damascus University, Syriam
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials